Drug Trial Radar · NCT07039916
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
Last checked: Nov 19, 2026Latest source record: Nov 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
231
Planned (sponsor's estimate)
Start
May 27, 2025
Primary completion
Dec 2027
Study completion Dec 2028
Sponsor
- Lead sponsor
- Immunovant Sciences GmbHIndustry
- Sponsor type
- Industry
- First posted
- Jun 26, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the study is to assess the efficacy, safety and tolerability of IMVT-1402 in adult participants with mild to severe generalized myasthenia gravis.
Conditions
- Generalized Myasthenia Gravis
Interventions
IMVT-1402Drug
• Dose 1 subcutaneous (SC) once weekly (QW) for 12 weeks (Period 1)
IMVT-1402Drug
* Dose 2 SC QW for 12 weeks (Period 1) * Dose 2 SC QW for 14 weeks (Period 2) * Dose 2 SC QW for 52 weeks (Period 3)
PlaceboDrug
• Placebo SC QW for 12 weeks (Period 1)
IMVT-1402Drug
* Dose 1 SC QW for 14 weeks (Period 2) * Dose 1 SC QW for 52 weeks (Period 3)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from Baseline in MG-ADL Score for Antibody-positive ParticipantsTime frame: Baseline to Week 12
Locations
93 sites in 15 countries. Site status is shown where the registry gives one.
Site Number - 1056
Huntsville, Alabama · Recruiting
Site Number - 1041
Mobile, Alabama · Recruiting
Site Number - 1017
Phoenix, Arizona · Recruiting
Site Number - 1025
Scottsdale, Arizona · Recruiting
Site Number - 1042
Tucson, Arizona · Recruiting
Site Number - 1010
Carlsbad, California · Withdrawn
Site Number - 1028
Irvine, California · Recruiting
Site Number - 1023
Los Angeles, California · Recruiting
Site Number - 1029
Rancho Mirage, California · Recruiting
Site Number - 1004
San Francisco, California · Recruiting
Site Number - 1053
Denver, Colorado · Recruiting
Site Number - 1027
Fort Collins, Colorado · Withdrawn
Site Number - 1001
New Haven, Connecticut · Recruiting
Site Number - 1024
Washington D.C., District of Columbia · Recruiting
Site Number - 1006
Clearwater, Florida · Recruiting
Site Number - 1008
Miami, Florida · Recruiting
Site Number - 1037
Ormond Beach, Florida · Recruiting
Site Number - 1002
Port Charlotte, Florida · Recruiting
Site Number - 1050
Rockledge, Florida · Recruiting
Site Number - 1007
Tampa, Florida · Recruiting
Site Number - 1014
Atlanta, Georgia · Recruiting
Site Number - 1043
Augusta, Georgia · Recruiting
Site Number - 1054
Schaumburg, Illinois · Recruiting
Site Number - 1022
Lexington, Kentucky · Recruiting
Site Number - 1032
Nicholasville, Kentucky · Recruiting
Site Number - 1046
New Orleans, Louisiana · Recruiting
Site Number - 1049
Foxborough, Massachusetts · Recruiting
Site Number - 1026
Detroit, Michigan · Recruiting
Site Number - 1005
East Lansing, Michigan · Recruiting
Site Number - 1018
Omaha, Nebraska · Recruiting
Site Number - 1019
Totowa, New Jersey · Withdrawn
Site Number - 1036
New York, New York · Recruiting
Site Number - 1034
New York, New York · Withdrawn
Site Number - 1020
Chapel Hill, North Carolina · Recruiting
Site Number - 1013
Durham, North Carolina · Recruiting
Site Number - 1044
Raleigh, North Carolina · Recruiting
Site Number - 1038
Cincinnati, Ohio · Recruiting
Site Number - 1045
Oklahoma City, Oklahoma · Recruiting
Site Number - 1011
Yukon, Oklahoma · Withdrawn
Site Number - 1031
Eugene, Oregon · Recruiting
Showing 40 of 93 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.